Based on the rapidity of post-deletion tumor latency in the older mice, it is likely that for some of these precancerous clones, oncogenic activation of wildtype p53 is the final or near-final barrier preventing conversion to a malignant tumor. The gene discussed is TP53; the disease is cancer.